Company Filing History:
1 out of 4 
1 out of 6 Years Active: 2013-2017
Title: Ana Maria Garcia Collazo: Innovator in Cancer Treatment
Introduction
Ana Maria Garcia Collazo is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel compounds. With a total of 2 patents, her work focuses on creating effective kinase inhibitors that target specific proteins involved in cancer progression.
Latest Patents
Her latest patents include "Tricyclic compounds for use as kinase inhibitors." This patent describes compounds that are useful in the treatment of diseases where inhibition of a protein or lipid kinase is desired, particularly in cancer treatment. The compounds are designed to inhibit PIM family kinases, such as PIM-1, PIM-2, and PIM-3. Another significant patent is "Imidazolothiadiazoles for use as protein kinase inhibitors." This invention also targets protein kinases, including PIM family kinases and PI3-K, to provide therapeutic options for cancer treatment.
Career Highlights
Ana Maria has worked with esteemed organizations such as the Centro Nacional de Investigaciones Oncológicas (CNIO) and the Fundación Centro Nacional de Investigaciones Oncológicas Carlos III. Her work in these institutions has been pivotal in advancing cancer research and developing new therapeutic strategies.
Collaborations
Throughout her career, Ana Maria has collaborated with notable colleagues, including Paolo Pevarello and Ana Belen Garcia Garcia. These collaborations have enriched her research and contributed to the success of her innovative projects.
Conclusion
Ana Maria Garcia Collazo stands out as a dedicated inventor in the field of oncology. Her innovative patents and collaborative efforts continue to pave the way for advancements in cancer treatment.